Alumis Insider Trades
NASDAQ: ALMSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 40 · $61.68M
- Sales
- 9 · $1.55M
- Shares bought / sold
- 5.82M / 116.08K
- Net activity
- Net buying $60.1 million
Alumis insider activity
Over the last 12 months, Alumis insiders reported 69 transactions on SEC Form 4: 40 open-market purchases and 9 sales. Insiders bought $61.7 million and sold $1.5 million worth of stock, for net insider buying of $60.1 million. The largest seller was AKKARAJU SRINIVAS, with $1.0 million in reported sales.
The most recent filing shows AKKARAJU SRINIVAS (Director) selling 48,066 shares at $10.55 on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ALMS's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
ALMS insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 8, 2026 | AKKARAJU SRINIVASDirector | Buy | 273,290 | $2.90M | Form 4 |
| Sep 8, 2026 | AKKARAJU SRINIVASDirector | Buy | 273,291 | $2.90M | Form 4 |
| Sep 8, 2026 | AKKARAJU SRINIVASDirector | Sale | 48,065 | $507.01K | Form 4 |
| Sep 8, 2026 | AKKARAJU SRINIVASDirector | Sale | 48,066 | $507.02K | Form 4 |
| Sep 4, 2026 | AKKARAJU SRINIVASDirector | Buy | 220,070 | $2.46M | Form 4 |
| Sep 4, 2026 | AKKARAJU SRINIVASDirector | Buy | 220,070 | $2.46M | Form 4 |
| Aug 3, 2026 | Goldstein David MChief Scientific Officer | Sale | 2,596 | $68.46K | Form 4 |
| Aug 3, 2026 | Bradley Mark ChristopherChief Development Officer | Sale | 2,572 | $67.82K | Form 4 |
| Aug 3, 2026 | Drappa JornChief Medical Officer | Sale | 2,447 | $64.53K | Form 4 |
| Aug 3, 2026 | Hardiman Roy C.Chief Business & Strategy Ofcr | Sale | 2,692 | $70.99K | Form 4 |
| Aug 3, 2026 | Schroer John R.Chief Financial Officer | Sale | 3,282 | $86.55K | Form 4 |
| Aug 3, 2026 | Pangali SanamChief Legal Officer | Sale | 1,364 | $35.97K | Form 4 |
| Jul 6, 2026 | Pangali SanamChief Legal Officer | Sale | 5,000 | $140.00K | Form 4 |
| Jul 6, 2026 | Pangali SanamChief Legal Officer | Option exercise | 5,000 | $25.30K | Form 4 |
| Jun 30, 2026 | AKKARAJU SRINIVASDirector | Award | 3,553 | — | Form 4 |
| Jun 30, 2026 | Machado PatrickDirector | Award | 3,553 | — | Form 4 |
| Jun 30, 2026 | Srivastava SapnaDirector | Award | 3,553 | — | Form 4 |
| Jun 30, 2026 | TETRAULT LYNN A.Director | Award | 3,553 | — | Form 4 |
| Jun 30, 2026 | Yao ZhengbinDirector | Award | 3,553 | — | Form 4 |
| May 22, 2026 | Drappa JornChief Medical Officer | Option exercise | 15,535 | $78.61K | Form 4 |
| May 22, 2026 | Drappa JornChief Medical Officer | Option exercise | 11,317 | $100.04K | Form 4 |
| Apr 1, 2026 | Tananbaum James B.Director | other | 680,486 | — | Form 4 |
| Apr 1, 2026 | Tananbaum James B.Director | other | 1,123,337 | — | Form 4 |
| Apr 1, 2026 | Tananbaum James B.Director | other | 1,123,337 | — | Form 4 |
| Apr 1, 2026 | Tananbaum James B.Director | other | 1,176,470 | — | Form 4 |
| Apr 1, 2026 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | other | 680,486 | — | Form 4 |
| Apr 1, 2026 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | other | 1,123,337 | — | Form 4 |
| Apr 1, 2026 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | other | 1,123,337 | — | Form 4 |
| Apr 1, 2026 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | other | 1,176,470 | — | Form 4 |
| Apr 1, 2026 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | other | 680,486 | — | Form 4 |
| Apr 1, 2026 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | other | 1,123,337 | — | Form 4 |
| Apr 1, 2026 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | other | 1,123,337 | — | Form 4 |
| Apr 1, 2026 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | other | 1,176,470 | — | Form 4 |
| Jan 9, 2026 | AKKARAJU SRINIVASDirector | Buy | 588,235 | $10.00M | Form 4 |
| Jan 8, 2026 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | Buy | 294,117 | $5.00M | Form 4 |
| Jan 8, 2026 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | Buy | 117,647 | $2.00M | Form 4 |
| Jan 8, 2026 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | Buy | 294,117 | $5.00M | Form 4 |
| Jan 8, 2026 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | Buy | 117,647 | $2.00M | Form 4 |
| Jan 8, 2026 | Tananbaum James B.Director | Buy | 294,117 | $5.00M | Form 4 |
| Jan 8, 2026 | Tananbaum James B.Director | Buy | 117,647 | $2.00M | Form 4 |
| Dec 5, 2025 | AKKARAJU SRINIVASDirector | Buy | 51,380 | $551.31K | Form 4 |
| Dec 5, 2025 | AKKARAJU SRINIVASDirector | Buy | 70,028 | $700.98K | Form 4 |
| Dec 5, 2025 | AKKARAJU SRINIVASDirector | Buy | 64,969 | $581.47K | Form 4 |
| Dec 4, 2025 | AKKARAJU SRINIVASDirector | Buy | 66,027 | $540.10K | Form 4 |
| Dec 3, 2025 | AKKARAJU SRINIVASDirector | Buy | 100,000 | $775.00K | Form 4 |
| Dec 2, 2025 | AKKARAJU SRINIVASDirector | Buy | 96,000 | $724.80K | Form 4 |
| Dec 1, 2025 | AKKARAJU SRINIVASDirector | Buy | 86,350 | $644.17K | Form 4 |
| Nov 28, 2025 | AKKARAJU SRINIVASDirector | Buy | 38,702 | $295.68K | Form 4 |
| Nov 26, 2025 | AKKARAJU SRINIVASDirector | Buy | 48,537 | $370.82K | Form 4 |
| Nov 21, 2025 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | Buy | 72,212 | $532.92K | Form 4 |
| Nov 21, 2025 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | Buy | 72,212 | $532.92K | Form 4 |
| Nov 21, 2025 | Tananbaum James B.Director | Buy | 72,212 | $532.92K | Form 4 |
| Nov 20, 2025 | AKKARAJU SRINIVASDirector | Buy | 125,743 | $905.35K | Form 4 |
| Nov 19, 2025 | AKKARAJU SRINIVASDirector | Buy | 137,772 | $903.78K | Form 4 |
| Nov 19, 2025 | Tananbaum James B.Director | Buy | 190,500 | $1.25M | Form 4 |
| Nov 19, 2025 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | Buy | 190,500 | $1.25M | Form 4 |
| Nov 19, 2025 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | Buy | 190,500 | $1.25M | Form 4 |
| Nov 18, 2025 | AKKARAJU SRINIVASDirector | Buy | 102,652 | $621.04K | Form 4 |
| Nov 18, 2025 | Tananbaum James B.Director | Buy | 117,374 | $726.55K | Form 4 |
| Nov 18, 2025 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | Buy | 117,374 | $726.55K | Form 4 |
| Nov 18, 2025 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | Buy | 117,374 | $726.55K | Form 4 |
| Nov 17, 2025 | AKKARAJU SRINIVASDirector | Buy | 914 | $5.04K | Form 4 |
| Nov 17, 2025 | Tananbaum James B.Director | Buy | 150,000 | $838.50K | Form 4 |
| Nov 17, 2025 | Tananbaum James B.Director | Buy | 50,000 | $280.00K | Form 4 |
| Nov 17, 2025 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | Buy | 150,000 | $838.50K | Form 4 |
| Nov 17, 2025 | Foresite Labs, LLC & Foresite Labs Affiliates 2021, LLC10% Owner | Buy | 50,000 | $280.00K | Form 4 |
| Nov 17, 2025 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | Buy | 150,000 | $838.50K | Form 4 |
| Nov 17, 2025 | Foresite Capital Management VI LLC & Foresite Capital Management V, LLC & Foresite Capital Fund V, L.P. & Foresite Capital Opportunity Management V, LLC & Foresite Capital Opportunity Fund V, L.P. & Foresite Capital Fund VI LP & Labs Co-Invest V, LLC & Foresite Labs Management I, LLC & Foresite Labs Fund I, L.P.10% Owner | Buy | 50,000 | $280.00K | Form 4 |
| Nov 13, 2025 | AKKARAJU SRINIVASDirector | Buy | 276,179 | $1.45M | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4